BIVI INVESTORS: Lead Plaintiff is Quickly Approaching; Contact Robbins LLP for Information About Your Rights
06. März 2024 18:21 ET
|
Robbins LLP
BioVie Inc. (BIVI) Allegedly Failed to Disclose Scientific Misconduct in Connection with its Clinical Trial
BIVI Shareholders Who Lost Money Should Contact Robbins LLP for Information about the BioVie Inc. Class Action
10. Februar 2024 00:51 ET
|
Robbins LLP
BioVie Inc. (BIVI) Allegedly Failed to Disclose Scientific Misconduct in Connection with its Clinical Trial
BioVie Inc. (BIVI) Stockholder News: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in BioVie Inc. Class Action
29. Januar 2024 19:27 ET
|
Robbins LLP
BioVie Inc. (BIVI) Allegedly Failed to Disclose Scientific Misconduct in Connection with its Clinical Trial
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against BioVie Inc. (BIVI)
23. Januar 2024 15:24 ET
|
Robbins LLP
BioVie Inc. (BIVI) Allegedly Failed to Disclose Scientific Misconduct in Connection with its Clinical Trial